Nanotechnology, Medical and MRI News -- Medical Growth Company Announces Expansion Into Nanotechnology Sector and Beta Testing Of MR Imaging Enhancement Technology With Digital Imaging Features

MRI, Radiology, Medical and Stock Investment News -- Medical growth company, NanoSignal Corporation (stock symbol = NNOS) is completing Beta testing of SLICES, new technology that improves MRI scanners by creating better images, allowing shorter scan times and reduced film consumption costs. Nanotechnology and Nanomedicine News -- The Company has also announced expansion plans to begin forging The New Nanotools of the 21st Century". In addition to reducing medical costs and providing doctors and radiologists with enhanced imagery through the use of SLICES NanoSignals next generation of products will deliver better information on the cellular. This will enable scientists and doctors to exhaustively inventory cells, cell parts and molecules within cell parts.

Las Vegas, NV (PRWEB) January 28, 2004 --Las Vegas, Nevada -- Medical growth company, NanoSignal Corporation (Stock Symbol = NNOS) continues to expand operations, offering investors a unique high return stock investment profit opportunity. See http://www.nnos.net

NEW MRI TECHNOLOHY - NanoSignals new Magnetic Resonance Imaging (MRI) enhancement technology product with digital imaging features, SLICES, allows doctors and radiologists to perform advanced MR imaging testing that goes beyond the capabilities of the standard MRI computer. The product is being Beta tested at Desert Radiology of Las Vegas. For news releases and more information on testing visit http://www.nnos.net/mri.htm

MEDICAL COST SAVINGS - SLICES offers a medical cost containment solution by allowing for shorter MR scan times (up to 50%) and reducing operating costs through reduced film consumption (from 30% to 80%) as well as extending the life of older MRI machines.

For complete details on the medical cost containment solution and benefits offered by this new technology visit http://www.nnos.net/medical-costs.htm

With testing completed a full marketing and sales campaign directed to MRI clinics, hospitals and radiology practice groups is set to begin.

EARLY STROKE DETECTION - See the new page http://www.nnos.net/stroke-detection.htm

NEW APPLICATIONS - CNN and the Wall Street Journal recently reported on new MRI applications including non-invasive autopsies and memory loss prediction. SLICES ability to provide enhanced imaging and increased data control and archiving opens up these new markets.

In addition, the Company is also developing blood flow monitor capabilities (http://www.nnos.net/blood-flow.htm) for use in cancer diagnosis and cardiovascular procedures. These advances would provide noninvasive, early analysis of vascular stricture and disease detection using current MRI machines.

NANOTECHNOLOGY and NANOMEDICINE EXPANSION -- The Companys stock symbol and name change reflects their expansion into the growing new sciences of nanotechnology and nanomedicine. See http://www.nnos.net/nanotechnology.htm

The next generation of SLICES is being developed to help research scientists and doctors exhaustively inventory cells, cell parts and molecules within cell parts.

NanoSignals corporate web site (http://www.nanosignalcorp.com) contains detailed information on the benefits and capabilities of SLICES.

Note: Certain statements in this news release may contain "forward looking statements" within the meaning of Private Securities Litigation Reform Act of 1995. These statements are subject to the safe harbor created by those rules. This release is for information purposes only. NanoSignal Corporation has neither approved nor disapproved this release. This release is not an offer or solicitation to buy securities. This information should not be considered to be any type of investment opinion or advice. These statements are not guarantees of future results or performance.

# # #